Stewart Appelrouth, Director at HEMISPHERX BIOPHARMA INC (HEB), bought 15,750 shares at $2.21 ($35K) on 2016-08-24, disclosed to the SEC on 2017-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |